diabetes. Non-insulin-dependent diabetes mellitus, Insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: At Intervention group, care training at home, including: patient training with presence at least one of the members of the family, on three training sessions of forty minutes will be r
At Intervention group, care training at home, including: patient training with presence at least one of the members of the family, on three training sessions of forty minutes will be received cares.
Sponsors
Vice chancellor for research, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for participants: (a) aged 20 years and over, (b) lack of participate in CME programs, (c) for conduct training, patients must be living with one family member, (d) the absence of any disease complications as: renal failure, blindness and … that physician approved its, (e) lack of any disease that effect on metabolic status, (f) to be literate for writing and reading, (h) ability to communicate, (I) not be member of the health team. Exclusion criteria: (a) A family history of diabetes, (b) moved without researcher informs.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: Before the intervention and three months after intervention. Method of measurement: Blood sample and laboratory measurement.;Hemoglobin A1C. Timepoint: Before the intervention and three months after intervention. Method of measurement: Blood sample and laboratory measurement.;Triglyceride. Timepoint: Before the intervention and three months after intervention. Method of measurement: Blood sample and laboratory measurement.;Cholesterol. Timepoint: Before the intervention and three months after intervention. Method of measurement: Blood sample and laboratory measurement.;Low Density Lipoprotein. Timepoint: Before the intervention and three months after intervention. Method of measurement: Blood sample and laboratory measurement.;High Density Lipoprotein. Timepoint: Before the intervention and three months after intervention. Method of measurement: Blood sample and laboratory measurement.;Body Mass Index. Timepoint: Baseline and 3 months after intervention. Method of measurement: (height)2 /(weight).;BP. Timepoint: Before the intervention and three months after intervention. Method of measurement: By sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist circumference measurement. Timepoint: Before the intervention and three months after intervention. Method of measurement: By cm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzaneh Miri
Hamadan University of Medical Sciences
Outcome results
None listed